SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001341004-14-000126
Filing Date
2014-02-14
Accepted
2014-02-14 08:24:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G, AMENDMENT NO. 2 sc13g.htm SC 13G/A 178256
2 EXHIBIT 1 - JOINT FILING AGREEMENT ex1.htm EX-99 19268
  Complete submission text file 0001341004-14-000126.txt   199208
Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Subject) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13G/A | Act: 34 | File No.: 005-86638 | Film No.: 14610631
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 146 TRIDENT CHAMBERS ROAD TOWN D8 TORTOLA
Business Address P.O. BOX 146 TRIDENT CHAMBERS ROAD TOWN D8 TORTOLA 852 3556 0183
Key Gate Investments Ltd (Filed by) CIK: 0001518232 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: SC 13G/A